Table 2.
The summary of prognostic data meta-analysis.
| Target molecule | Survival type | Number of Studies | Hazard ratio | Confidence interval | P value of HR | I 2 | P value of I2 |
|---|---|---|---|---|---|---|---|
| Cyclin B1 | OS | 7 | 1.69 | 1.35–2.12 | <.01 | 23% | .25 |
| DSS | 2 | 1.71 | 1.37–2.13 | <.01 | 0% | .82 | |
| DFS | 7 | 2.01 | 1.18–3.42 | .01 | 73% | <.01 | |
| Cyclin B2 | DSS | 4 | 2.46 | 1.19–5.07 | .02 | 91% | <.01 |
DFS = disease free survival, DSS = disease specific survival, OS = overall survival.